1 |
II-3 |
M |
18.5 |
Delayed puberty. Micropenis. Tanner stage 3. Testicular volume 3 mL |
Normal |
Surgery for right-sided cryptorchidism at age 1.5 years |
FSH 1.2 IU/mL (1.0–8.0); LH 0.5 IU/mL (0.7–7.2); total testosterone 0.20 ng/mL (2.60–10.00) |
GNRHR p.[Val134Gly];[Arg139Cys] (compound heterozygous) |
2 |
II-1 |
M |
22 |
Delayed puberty. Tanner stage 1. Testicular volume 5 mL |
Normal |
|
FSH 2.4 IU/mL (2.5–10.2); LH <0.1 IU/mL (1.9–2.5); total testosterone 0.33 ng/mL (2.60–10.00) |
GNRHR p.[Gln106Arg];[Phe313Metfs*3] (compound heterozygous) |
|
II-2 |
F |
18 |
Primary amenorrhea |
Normal |
|
FSH 2.2 IU/mL (2.5–10.2); LH 0.9 IU/mL (1.9–2.5); estradiol 15 pg/mL (11–69) |
GNRHR p.[Gln106Arg];[Phe313Metfs*3] (compound heterozygous) |
3 |
II-2 |
M |
51 |
Delayed puberty. Tanner stage 1. Testicular volume 5 mL |
Normal |
Low bone mineral density (lumbar spine T-score −2.3; femoral neck T-score −2.8) |
FSH 1.1 IU/mL (1.0–8.0); LH 0.4 IU/mL (0.7–7.2); total testosterone 0.40 ng/mL (2.70–11.00) |
GNRHR p.[Arg262Gln];[Phe313Metfs*3] (compound heterozygous) |
4 |
II-2 |
M |
n/a |
n/a |
n/a |
|
n/a |
GNRHR p.[Tyr283His];[Tyr283His] (homozygous) |
|
II-4 |
F |
n/a |
Primary amenorrhea |
Normal |
|
FSH 0.4 IU/mL (1.5–33.4); LH <0.07 IU/mL (1.7–15.0); estradiol <11.8 pg/mL (19.5–356.7) |
GNRHR p.[Tyr283His];[Tyr283His] (homozygous) |
|
II-5 |
F |
39 |
Primary amenorrhea |
Normal |
Low bone mineral density (lumbar spine T-score −3.2; femoral neck T-score −1.0). Hypercholesterolemia. Secondary sex characteristics had developed due to oral contraceptive use in adolescence |
FSH 0.7 IU/mL (4.0–13.0); LH 0.1 IU/mL (1.7–15.0); estradiol <10 pg/mL (20–150) |
GNRHR p.[Tyr283His];[Tyr283His] (homozygous) |
5 |
II-1 |
M |
15 |
Delayed puberty. Tanner stage 1. Testicular volume <5 mL |
Normal |
Surgery for left-sided cryptorchidism at age 10 years |
FSH 0.5 IU/mL (1.4–18.0); LH 0.7 IU/mL (1.5–9.3); total testosterone 0.09 ng/mL (2.20–8.00) |
GNRHR p.Val134Gly (heterozygous) + PROKR2 p.Arg80Cys (heterozygous) |